- Gene Editing Shows Promise in Sickle-Cell Disease The Wall Street Journal
- Gene-editing treatment shows promise for sickle cell disease CTV News
- Editas Medicine Announces Preclinical Data and Large-Scale Manufacturing Process for EDIT-301, in Development for the Treatment of Sickle Cell Disease and Beta-Thalassemia Yahoo Finance
- Sickle Cell, Beta Thalassemia Treatment: Gene-Editing Tool Crispr Shows Promise Bloomberg
- CRISPR and another genetic strategy fix cell defects in two common blood disorders Science Magazine
- View Full coverage on Google News